Notification of Full Year Results

RNS Number : 6483Z

Immupharma PLC

20 March 2012

 



FOR IMMEDIATE RELEASE                                                                           20 MARCH 2012

ImmuPharma plc

Notification of Full Year Results

Date: 27 March 2012

ImmuPharma plc (AIM: IMM), the specialist drug development company, is scheduled to announce its Preliminary Results for the year ended 31 December 2011 on Tuesday 27 March 2012.

A lunch briefing for analysts and private client brokers will be held at 12.00pm on the day of the results at the offices of Buchanan, 107 Cheapside, London EC2V 6DN.

- Ends -

For further information please contact:

ImmuPharma plc	+ 44 (0) 20 7152 4080
Dimitri Dimitriou, Chief Executive Officer
Lisa Baderoon, Head of Investor Relations [e-mail]	+ 44 (0) 7721 413496
Buchanan	+ 44 (0) 20 7466 5000
Mark Court, Jessica Fontaine
Panmure, Gordon & Co., NOMAD & Broker	[phone]
Andrew Burnett
Rakesh Sharma
Espirito Santo Investment Bank	[phone]
James Bromhead
Richard Crawley

 

END

 

 

NORKMGMFNLMGZZM